| The effect of capital structure on the profitability of pharmaceutical companies the case of Iran M Mohammadzadeh, F Rahimi, F Rahimi, SM Aarabi, J Salamzadeh Iranian journal of pharmaceutical research: IJPR 12 (3), 573, 2013 | 81 | 2013 |
| Patient preferences for Interferon-beta in Iran: A discrete choice experiment F Rahimi, HR Rasekh, E Abbasian, F Peiravian, M Etemadifar, F Ashtari, ... PLoS One 13 (3), e0193090, 2018 | 7 | 2018 |
| Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment G Afsharmanesh, F Rahimi, L Zarei, F Peiravian, G Mehralian Journal of Pharmaceutical Policy and Practice 14, 1-7, 2021 | 5 | 2021 |
| Costs and outcomes of colorectal cancer screening program in Isfahan, Iran F Rahimi, R Rezayatmand, J Shojaeenejad, E Tabesh, Z Ravankhah, ... BMC Health Services Research 23 (1), 13, 2023 | 4 | 2023 |
| Cost‐effectiveness of colorectal cancer screening strategies: A systematic review F Gheysariyeha, F Rahimi, E Tabesh, MR Hemami, P Adibi, ... European Journal of Cancer Care, e13673, 2022 | 4 | 2022 |
| Use of a biosynthetic wound dressing to treat burns: a systematic review F Rahimi, R Rezayatmand Journal of Wound Care 29 (Sup12), S16-S22, 2020 | 3 | 2020 |
| Evaluation of Affordability and Impoverishment Effect of Cardiovascular Medicines in Iran: Effect of cardiovascular medicines in Ira AV Farahani, HR Rasekh, S Najafi, M Akbari, F Rahimi, F Salehnia, ... Iranian Journal of Pharmaceutical Sciences 14 (2), 65-74, 2018 | 3 | 2018 |
| Cost of illness of multiple sclerosis in Isfahan, Iran, from a social perspective: a comparison of the human-capital and friction-cost methods M Amirsadri, F Rahimi, A Khajepour Value in Health Regional Issues 30, 26-30, 2022 | 2 | 2022 |
| Cost-Effectiveness Analysis of Molecular Screening to Identify Lynch Syndrome in the Patients with Colorectal Cancer H Azardoost, F Rahimi, M Zeinalian, R Rezayatmand International Journal of Cancer Management 14 (4), 2021 | 2 | 2021 |
| Cost evaluation of chemotherapy and epidemiology of five most common cancers in Isfahan Province in Iran M Amirsadri, AH Zargarzadeh, F Rahimi, F Jahani Tehran University Medical Journal 78 (4), 226-232, 2020 | 1 | 2020 |
| Using discrete choice experiment to determine willingness to pay for interferon-beta drugs by multiple sclerosis patients F Rahimi, HR Rasekh, F Peiravian, E Abbasian Iranian Journal of Pharmaceutical Sciences, 71-78, 2018 | 1 | 2018 |
| Selecting Reference Countries in External Reference Based Pricing: The Case Study of Iran: Selecting reference countries in external reference based pricing F Rahimi, HR Rasekh, E Abbasian, F Peiravian Iranian Journal of Pharmaceutical Sciences 14 (3), 36-48, 2018 | 1 | 2018 |
| The Effect of Capital Structure on the Profitability of Pharmaceutical Companies The Case of Iran F Rahimi Brieflands, 2013 | 1 | 2013 |
| Economic Burden of Colorectal Cancer: A Scoping Review K Fatehi, F Rahimi, R Rezayatmand Payavard Salamat 17 (1), 70-85, 2023 | | 2023 |
| The Economic Impact of COVID-19 and Related Coping and Resilience Strategies: The Experience of Iranian Households L Zarei, F Rahimi, ST Heydari, E Parcham, KB Lankarania Health Behavior and Policy Review 9 (4), 996-1008, 2022 | | 2022 |
| Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer F Rahimi, M Zeinalian, R Rezayatmand Iranian Journal of Breast Disease 14 (4), 75-93, 2022 | | 2022 |
| The Cost of Care Package for Patient with Hepatitis C A Jabbari, F Rahimi, RS Salmanzadeh, M Masoudnia Journal of Health Information Management 19 (486002781), 191-198, 2022 | | 2022 |
| PCN33 Cost-Effectiveness of Molecular Screening to Identify Lynch Syndrome in Iranian Patients with Colorectal Cancer H Azardoost, F Rahimi, M Zeinalian, R Rezayatmand Value in Health Regional Issues 22, S10-S11, 2020 | | 2020 |
| A new approach to pharmaceutical pricing based on patients’ willingness to pay F Rahimi, HR Rasekh, E Abbasian, F Peiravian Tropical Medicine & International Health 23 (12), 1326-1331, 2018 | | 2018 |
| Patient Preferences for Interferon-Beta in Iran: A Discrete Choice Experiment F Rahimi, HR Rasekh, F Peiravian Value in Health 20 (9), A726, 2017 | | 2017 |
